Announcements Trials

Browse Landscape

Phase

Status

Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 24 Biopsy 16 Magnetic Resonance Spectroscopy 15 Cyclophosphamide 5 Bevacizumab 4 Vincristine 3 Taxes 3 Prednisone 3 Nivolumab 3 Doxorubicin 3 Cetuximab 3 Azacitidine 3 venetoclax 2 trastuzumab deruxtecan 2 prednylidene 2 olaparib 2 iadademstat 2 deltacortene 2 decitabine and cedazuridine drug combination 2 X-Rays 2 Surgical Procedures, Operative 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Practice Guidelines as Topic 2 Paclitaxel 2 Ipilimumab 2 Immunoglobulin G 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × sotigalimab × 30 days × Clear all

NCT05419479 2026-06-04

Switch Maintenance in Pancreatic

Dana-Farber Cancer Institute

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡